Orion Integrated Biosciences

Orion Integrated Biosciences is a private, U.S. government-funded biodefense company specializing in AI-driven threat detection and response platforms. Its core technology, the RIGEL analytical system, integrates disparate data sources to identify and characterize known and unknown biothreats, supporting decision-making for government agencies. The company operates as a government contractor and research partner, leveraging strategic alliances with the Department of Defense, DHS, and other agencies to advance its pipeline of detection and countermeasure programs. Its business model is centered on platform development and services for the defense and security sectors.

RIGEL Biodefense Analytical Enterprise: An AI-powered data integration and analysis platform that aggregates global travel, trade, and transportation data with disease databases to detect, characterize, and assess biological threats in near real-time, supporting decision-making for countermeasures.

Orion competes in the biodefense analytics and threat detection space against larger defense contractors (e.g., Leidos, Battelle) and other specialized biotech firms focused on diagnostics. Its niche focus on AI-driven, multi-source data integration for 'unknown' threats provides differentiation, but it faces competition for limited government funding.